MG

Michael Grunkin

CEO

Visiopharm

Copenhagen, Capital Region of Denmark


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Visiopharm
Industry
research
Employees
110.0
Seniority
C suite
Annual Revenue
12422000.0
Total Funding
14698942.0
Latest Funding
Venture (Round not Specified)

Professional Summary

Michael Grunkin serves as CEO at Visiopharm. Visiopharm operates in the research sector with approximately 110.0 employees. The company is headquartered in Copenhagen, Capital Region of Denmark. Visiopharm generates annual revenue of 12422000.0. To date, Visiopharm has raised 14698942.0 in total funding, with the most recent round being Venture (Round not Specified).

Industry & Role Insights

  • MessageCEO tracks 2,961 executives in the research sector.
  • 947 executive contacts are available in Capital Region of Denmark.
  • Our database includes 201,469 c suite-level executives.

Technologies

Outlook Hubspot Atlassian Cloud Google AdWords Conversion Hotjar Google Analytics Nginx Vimeo Wistia Mobile Friendly Twitter Advertising WordPress.org Apache HeapAnalytics Google Tag Manager

Keywords

cancer diagnostics cancer research image analysis stereology quantitative digital pathology biomarker development tissue micro array management pathology tissue section alignment digital pathology spatial biology biotechnology research ai-driven pathology precision pathology image analysis software ce-ivd apps deep learning multiplex imaging tissue analysis diagnostic decision support tissue microarray automated analysis tumor detection cell segmentation biomarker analysis image processing ihc staining consistency scientific research data visualization batch processing high-throughput screening quality control diagnostic imaging machine learning tools customizable workflows phenotyping software quantitative analysis pathology solutions research applications ai algorithms neural network training sop compliance pacs integration diagnostic algorithms tissue characterization image registration virtual multiplexing molecular pathology data export tissue section analysis clinical diagnostics pathologist collaboration workflow automation digital imaging scanned slide analysis ai accuracy predictive analytics real-time data validation clinical decision making advanced analytics tools precision diagnostics regulatory compliance customizable applications tissue mining healthcare technology biopharmaceutical research academic research workflow integration clinical applications automation user-friendly interface global reach market leader innovation in healthcare research support diagnostic accuracy efficiency in pathology pathology labs contract research organizations healthcare ai solutions advanced imaging technology tissue profiling diagnostic software solutions artificial intelligence information technology & services enterprise software enterprises computer software b2b

Related Executives

SN
Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.
SD
Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.
M
Mark Chief Executive Officer at 23Strands
IT
Ilia Tikhomirov Chief Executive Officer at 35Pharma
AD
Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Michael Grunkin in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Visiopharm.

Michael Grunkin's Position in the MessageCEO Database

  • Michael Grunkin is 1 of 1 verified executive contact we track at Visiopharm.
  • 2,871 verified executive contacts in research are in the MessageCEO database.
  • 942 verified executive contacts in Capital Region of Denmark are in the database.
  • 77 verified contacts work at research companies in the 110.0 employee range (same size as Visiopharm).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated June 2026.

Frequently Asked Questions

How do I reach Michael Grunkin directly?

Michael Grunkin's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Visiopharm. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Michael Grunkin work for?

Michael Grunkin is CEO at Visiopharm, a company in the research sector with 110.0 employees. The company is based in Copenhagen, Capital Region of Denmark.

Can I pitch or sell to Michael Grunkin?

As CEO at Visiopharm, Michael Grunkin is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Michael Grunkin directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Michael Grunkin in?

Michael Grunkin works in the research industry as CEO at Visiopharm. MessageCEO provides verified contact information for executives across all major industries.

Is Michael Grunkin's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Michael Grunkin's profile is kept up-to-date with the latest available information.

Verified Profile
Last updated: June 22, 2026

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans